Yayın:
Polymorphisms and Protein Expressions of Glutathione S-Transferase M1 and T1 in Non-Small Cell Lung Cancer

dc.contributor.authorKilic, Murat
dc.contributor.authorAda, Ahmet Oguz
dc.contributor.authorOguztuzun, Serpil
dc.contributor.authorDemirag, Funda
dc.contributor.authorCelik, Sezgin
dc.contributor.authorBicakcioglu, Pinar
dc.contributor.authorIscan, Mumtaz
dc.date.accessioned2026-06-27T14:07:27Z
dc.date.issued2017
dc.description.abstractObjectives: The deletion polymorphisms of glutathione S-transferase (GST) GSTM1 and GSTT1 genes result in the absence of the corresponding protein, which decreases the detoxification of carcinogens. Studies evaluating polymorphisms and protein expressions in the same patients are limited. Therefore, in this study, we aimed to investigate the association between polymorphisms and protein expressions of GSTM1 and GSTT1 in lung tissues of patients with non-small cell lung cancer (NSCLC). Materials and Methods: For protein expression and gene deletion studies, tumor and surrounding tumor free (normal) tissue of 33 patients with NSCLC were used. In paraffin-embedded tissues, immunohistochemistry was used to detect protein expressions, and multiplex polymerase chain reaction amplification was used to identify gene deletions. Results: GSTM1 and GSTT1 protein expressions were not detected in patients with GSTM1 and GSTT1 gene deletions, whereas protein expressions were detected in lung tissues of all patients carrying GSTM1 and GSTT1 genes. The protein expression level of GSTT1 was 2.0-fold higher in tumors of patients lacking GSTM1 genes than those with GSTM1 genes (p=0.018). Protein expression of GSTM1 was statistically higher in tumor tissues than in normal tissues of patients with GSTM1 genes (p=0.001). Conclusion: These results show that a) there is an association between gene deletions and protein expressions of GSTM1 and GSTT1 in patients with NSCLC, b) in the absence of GSTM1 genes, enhancement of expression of GSTT1 in tumors is likely to show that GSTT1 increases its capacity to detoxify the toxic electrophiles in tumors, and c) GSTM1 protein expression is higher in tumors compared with normal lung tissues of patients with NSCLC.en
dc.description.sponsorshipKirikkale University, Coordination Unit of Scientific Research Projects [2011/16]
dc.description.urihttps://doi.org/10.4274/tjps.74745
dc.identifier.doi10.4274/tjps.74745
dc.identifier.endpage242
dc.identifier.issn1304-530X
dc.identifier.issue3
dc.identifier.pubmed32454619
dc.identifier.startpage237
dc.identifier.urihttps://hdl.handle.net/20.500.14981/57292
dc.identifier.volume14
dc.identifier.wos000417379400004
dc.language.isoeng
dc.publisherTURKISH PHARMACISTS ASSOC
dc.relation.ispartofTURKISH JOURNAL OF PHARMACEUTICAL SCIENCES
dc.rightsopenAccess
dc.subjectGSTM1
dc.subjectGSTT1
dc.subjectpolymorphism
dc.subjectprotein expression
dc.subjectnon-small cell lung carcinoma
dc.subjectGSTP1 POLYMORPHISMS
dc.subjectTURKISH POPULATION
dc.subjectRISK
dc.subjectGENOTYPE
dc.subjectCYTOCHROME-P450
dc.subjectASSOCIATION
dc.subjectMETABOLISM
dc.subjectTUMOR
dc.subjectPharmacology & Pharmacy
dc.titlePolymorphisms and Protein Expressions of Glutathione S-Transferase M1 and T1 in Non-Small Cell Lung Cancer
dc.typeArticle
dspace.entity.typePublication
local.import.sourceWOS

Dosyalar

Koleksiyonlar